Tech Center 1600 • Art Units: 1682 1693
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17922930 | METHODS AND SYSTEMS FOR MONITORING ORGAN HEALTH AND DISEASE | Final Rejection | ILLUMINA, INC. |
| 18269593 | METHODS FOR ANALYTE CAPTURE DETERMINATION | Non-Final OA | 10x Genomics, Inc. |
| 17923007 | SPATIAL TRANSCRIPTOMIC TRANSFER MODES | Final Rejection | 10x Genomics, Inc. |
| 17877760 | ONE STEP IN SITU ROLLING CIRCLE AMPLIFICATION ASSAY | Final Rejection | 10x Genomics, Inc. |
| 17724977 | METHODS AND DEVICES FOR SPATIAL ASSESSMENT OF RNA QUALITY | Final Rejection | 10x Genomics, Inc. |
| 17620077 | DIGITAL PCR MEASUREMENT METHOD AND MEASUREMENT DEVICE | Non-Final OA | Hitachi, Ltd. |
| 17687276 | SINGLE-CELL LEVEL CONNECTOMICS USING A DNA-SYNTHESIS BASED BARCODING SYSTEM AND METHODS OF USING THE SAME | Final Rejection | Northwestern University |
| 17413802 | TILED ASSAYS USING CRISPR-CAS BASED DETECTION | Final Rejection | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18296915 | TRANSMEMBRANE SENSORS AND MOLECULAR AMPLIFIERS FOR LYSIS-FREE DETECTION OF INTRACELLULAR TARGETS | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17908279 | PREDICTION OF RADIOTHERAPY RESPONSE FOR PROSTATE CANCER SUBJECT BASED ON T-CELL RECEPTOR SIGNALING GENES | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18044289 | IMPROVED HIGH EFFICIENCY TARGETED IN SITU GENOME-WIDE PROFILING | Non-Final OA | Fred Hutchinson Cancer Center |
| 17995058 | Methods, Compositions, and Kits for Identifying Regions of Genomic DNA Bound to a Protein | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17486936 | METHODS FOR MODIFYING TRANSLATION | Final Rejection | RAMOT AT TEL-AVIV UNIVERSITY LTD. |
| 17775932 | Methods and Kits using Internal Standards to Control for Complexity of Next Generation Sequencing(NGS) Libraries | Final Rejection | The University of Toledo |
| 17612635 | METHOD FOR AMPLIFYING AND DETECTING RIBONUCLEIC ACID (RNA) FRAGMENTS | Final Rejection | ACADEMIA SINICA |
| 17556774 | Rehydration Buffer Solutions and Methods | Final Rejection | LIFE TECHNOLOGIES CORPORATION |
| 18037693 | ASSESSING RISK FOR COLORECTAL ADENOMA RECURRENCE BY NONINVASIVE MEANS | Non-Final OA | The Chinese University of Hong Kong |
| 18250899 | PROGNOSTIC GENE SIGNATURE AND METHOD FOR DIFFUSE LARGE B-CELL LYMPHOMA PROGNOSIS AND TREATMENT | Non-Final OA | The Children’s Mercy Hospital |
| 17925297 | Methods, Systems, and Compositions for the Analysis of Cell-Free Nucleic Acids | Non-Final OA | Sequenom, Inc. |
| 18046896 | DNA RECOMBINASE MEDIATED ASSEMBLY OF DNA LONG ADAPTER SINGLE STRANDED OLIGONUCLEOTIDE (LASSO) PROBES | Final Rejection | Rutgers, The State University of New Jersey |
| 17859770 | PAIRED-END SEQUENCING METHODS AND COMPOSITIONS | Non-Final OA | Pacific Biosciences of California, Inc. |
| 17778598 | SMALL UNANNOTATED, NON-CODING RNAS FOR THE DETECTION OF LIVER CANCER | Final Rejection | Icahn School of Medicine at Mount Sinai |
| 18073397 | 3 FLAP OKAZAKI FRAGMENTS AND USES THEREOF | Non-Final OA | City of Hope |
| 17806238 | METHODS AND COMPOSITIONS FOR CANCER DETECTION, CHARACTERIZATION OR MANAGEMENT IN COMPANION ANIMALS | Non-Final OA | Zoetis Services LLC |
| 17561408 | MOLECULAR SUBTYPING, PROGNOSIS, AND TREATMENT OF BLADDER CANCER | Final Rejection | The University of British Columbia |
| 18010873 | COMPOSITIONS AND METHODS FOR IN SITU SINGLE CELL ANALYSIS USING ENZYMATIC NUCLEIC ACID EXTENSION | Final Rejection | Bruker Spatial Biology, Inc. |
| 18253272 | DETECTING METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH THROUGHPUT SEQUENCING | Non-Final OA | NUCLEIX LTD. |
| 17998113 | METHODS FOR SIMULTANEOUSLY DETECTING TARGET NUCLEIC ACIDS AND PROTEINS AND A KIT THEREOF | Final Rejection | ADVANCED CELL DIAGNOSTICS, INC. |
| 18486005 | SAMPLE PREPARATION METHODS, SYSTEMS AND COMPOSITIONS | Non-Final OA | Karius, Inc. |
| 18334327 | METHODS AND COMPOSITIONS FOR PERFORMING A DETECTION ASSAY | Non-Final OA | Mammoth Biosciences, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy